F.C.C. Co., Ltd.
F.C.C. Co., Ltd. (FCVFF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for F.C.C. Co., Ltd. (FCVFF), covering cash flow, earnings, and balance sheets.
F.C.C. Co., Ltd. (FCVFF) Income Statement & Financial Overview
Review F.C.C. Co., Ltd. FCVFF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $66.86B | $62.43B | $63.19B | $64.13B |
| Cost of Revenue | $52.85B | $50.90B | $51.28B | $52.30B |
| Gross Profit | $14.02B | $11.54B | $11.92B | $11.83B |
| Gross Profit Ratio | $0.21 | $0.18 | $0.19 | $0.18 |
| R&D Expenses | $0.00 | $2.36B | $1.97B | $2.12B |
| SG&A Expenses | $11.67B | $5.88B | $5.04B | $4.90B |
| Operating Expenses | $11.67B | $5.86B | $7.01B | $6.89B |
| Total Costs & Expenses | $64.52B | $56.76B | $58.29B | $59.19B |
| Interest Income | $582.00M | $955.00M | $55.00M | $1.69B |
| Interest Expense | $341.00M | $0.00 | $1.51B | $7.00M |
| Depreciation & Amortization | $2.99B | $3.04B | $3.03B | $3.12B |
| EBITDA | $5.19B | $8.71B | $8.17B | $8.06B |
| EBITDA Ratio | $0.08 | $0.14 | $0.13 | $0.13 |
| Operating Income | $2.35B | $5.67B | $4.91B | $4.94B |
| Operating Income Ratio | $0.04 | $0.09 | $0.08 | $0.08 |
| Other Income/Expenses (Net) | -$484.00M | $2.26B | -$1.15B | $1.69B |
| Income Before Tax | $1.86B | $7.94B | $3.63B | $6.63B |
| Income Before Tax Ratio | $0.03 | $0.13 | $0.06 | $0.10 |
| Income Tax Expense | -$777.00M | $2.40B | $511.00M | $2.01B |
| Net Income | $2.63B | $5.52B | $3.11B | $4.59B |
| Net Income Ratio | $0.04 | $0.09 | $0.05 | $0.07 |
| EPS | $54.50 | $112.98 | $63.26 | $92.78 |
| Diluted EPS | $54.50 | $112.98 | $63.26 | $92.78 |
| Weighted Avg Shares Outstanding | $48.37M | $48.87M | $49.10M | $49.52M |
| Weighted Avg Shares Outstanding (Diluted) | $48.37M | $48.87M | $49.10M | $49.52M |
Over the past four quarters, F.C.C. Co., Ltd. demonstrated steady revenue growth, increasing from $64.13B in Q1 2024 to $66.86B in Q4 2024. Operating income reached $2.35B in Q4 2024, maintaining a consistent 4% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $5.19B, reflecting operational efficiency. Net income dropped to $2.63B, with EPS at $54.50. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan